These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6771274)

  • 1. Dopaminergic inhibition of ionophore A23187-stimulated release of prolactin from rat anterior pituitary cells.
    Tam SW; Dannies PS
    J Biol Chem; 1980 Jul; 255(14):6595-9. PubMed ID: 6771274
    [No Abstract]   [Full Text] [Related]  

  • 2. The possible involvement of both calcium and cyclic AMP in the dopaminergic inhibition of prolactin secretion.
    Merritt JE; Brown BL
    Life Sci; 1984 Aug; 35(7):707-11. PubMed ID: 6206370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of calcium ions in dopamine inhibition of prolactin secretion from sheep pituitary cells.
    Ray KP; Wallis M
    Mol Cell Endocrinol; 1982; 28(3):691-703. PubMed ID: 6818058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
    Delbeke D; Dannies PS
    Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
    Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin modulates prolactin secretion in vitro: studies with calmodulin containing liposomes.
    Schettini G; Florio T; Meucci O; Landolfi E; Cronin MJ; MacLeod RM
    Life Sci; 1987 Nov; 41(22):2437-44. PubMed ID: 2824954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of TGF-beta1 on prolactin synthesis and secretion: an in-vitro study.
    Coya R; Alvarez CV; Perez F; Gianzo C; Diéguez C
    J Neuroendocrinol; 1999 May; 11(5):351-60. PubMed ID: 10320562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
    Cronin MJ; Thorner MO
    J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
    Schettini G; Cronin MJ; MacLeod RM
    Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine decreases 7315a tumor cell prolactin release induced by calcium mobilization.
    Judd AM; Koike K; Schettini G; Login IS; Hewlett EL; Yasumoto T; MacLeod RM
    Endocrinology; 1985 Sep; 117(3):1215-21. PubMed ID: 3926467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
    Dutt A; Juneja HS
    Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reserpine inhibits rat anterior pituitary hormone secretion in vitro: effects on prolactin and ACTH and ultrastructural observations.
    Login IS; Cronin MJ; Lamberts SW; Valdenegro CA; MacLeod RM
    Brain Res; 1983 Jan; 260(1):99-106. PubMed ID: 6297687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine does not attenuate phosphoinositide hydrolysis in rat anterior pituitary cells.
    Canonico PL; Jarvis WD; Judd AM; MacLeod RM
    J Endocrinol; 1986 Sep; 110(3):389-93. PubMed ID: 3020141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ornithine decarboxylase in guinea pig lymphocytes by the divalent cation ionophore A23187 and phytohemagglutinin.
    Otani S; Matsui I; Nakajima S; Masutani M; Mizoguchi Y; Morisawa S
    J Biochem; 1980 Jul; 88(1):77-85. PubMed ID: 6773932
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible involvement of dopamine in the release of prolactin-like hormone from bullfrog pituitary gland.
    Kikuyama S; Seki T
    Gen Comp Endocrinol; 1980 Jun; 41(2):173-9. PubMed ID: 6968286
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual effects of manganese on prolactin secretion.
    Merritt JE; Brown BL
    Cell Calcium; 1984 Apr; 5(2):159-65. PubMed ID: 6428747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of patterns of prolactin release in GH4C1 cells and primary pituitary cultures.
    Delbeke D; Kojima I; Dannies PS
    Mol Cell Endocrinol; 1985 Nov; 43(1):15-22. PubMed ID: 3934015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic reduction of intracellular calcium: the role of calcium influx.
    Login IS; Judd AM; MacLeod RM
    Biochem Biophys Res Commun; 1988 Mar; 151(2):913-8. PubMed ID: 3348820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Bromo-alpha-ergocryptine causes degradation of prolactin in primary cultures of rat pituitary cells after chronic treatment.
    Dannies PS; Rudnick MS
    J Biol Chem; 1980 Apr; 255(7):2776-81. PubMed ID: 7358708
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells.
    Tam SW; Dannies PS
    Endocrinology; 1981 Aug; 109(2):403-8. PubMed ID: 6166464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.